Sentinel node mapping for intra-thoracic malignancies: systematic review of the best available evidence

Introduction: Sentinel node mapping is a new technique of lymph nodal staging in solid tumors, which can decrease the morbidity of regional lymph node dissection considerably. Intra-thoracic tumors including non-small cell lung cancer (NSCLC) and esophageal carcinoma (EC) are among the solid tumors in which sentinel node (SN) mapping has been applied. In the current systematic review, we gathered the best available evidence (systematic reviews) in this regard and presented the results in a systematic review format.Material and methods: We searched MEDLINE and SCOPUS since the inception till 13 December 2014 using the following keywords: (lung OR esophagus OR esophageal) AND sentinel AND (“systematic review” OR meta-analysis OR metaanalysis). No language limit was imposed on the search strategy. Systematic reviews and meta-analyses on SN mapping in EC or NSCLC were included in the current study. Narrative review articles were excluded from the study.Results: Overall five systematic review were included. One of the included studies was on SN mapping in NSCLC and four were on EC. Overall detection rate and sensitivity for EC and NSCLC were high and both were related to mapping technique, pathological involvement of the mediastinal nodes, size and location of the tumors.Conclusion: SN mapping is feasible and highly accurate in EC and NSCLC. Attention to the technique (using radiotracers, peri-tumoral injection) and restriction of the patients to less advanced cases (cN0 and T1, 2) would ensure the best results with high detection rate and sensitivity.

[1]  R. Sadeghi,et al.  Sentinel node mapping diagnostic studies warrant a unique reporting criteria: comment on Xiong et al. systematic review. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[2]  G. Eslick,et al.  Sentinel lymph node in oesophageal cancer-a systematic review and meta-analysis. , 2014, Journal of gastrointestinal oncology.

[3]  M. Keshtgar,et al.  Added value of blue dye injection in sentinel node biopsy of breast cancer patients: do all patients need blue dye? , 2014, International journal of surgery.

[4]  C. Castoro,et al.  Minimally invasive surgery for esophageal cancer: a review on sentinel node concept , 2014, Surgical Endoscopy.

[5]  D. Krag,et al.  Accuracy of sentinel node biopsy in esophageal carcinoma: a systematic review and meta-analysis of the pertinent literature , 2014, Surgery Today.

[6]  A. B. Wedding,et al.  Clinical relevance of novel imaging technologies for sentinel lymph node identification and staging. , 2014, Biotechnology advances.

[7]  R. Sadeghi,et al.  Sentinel lymph node biopsy algorithm: can it be a universal method for midline tumors? , 2014, Gynecologic oncology.

[8]  R. Sadeghi,et al.  Sentinel node mapping in esophageal squamous cell carcinoma using intra-operative combined blue dye and radiotracer techniques , 2013, Esophagus.

[9]  R. Sadeghi,et al.  Accuracy of sentinel node biopsy in the staging of non-small cell lung carcinomas: systematic review and meta-analysis of the literature. , 2013, Lung cancer.

[10]  P. Mildenberger,et al.  Detection of lymph node metastases in esophageal cancer , 2011, Expert review of anticancer therapy.

[11]  R. Sadeghi,et al.  Anaphylaxis reaction of a breast cancer patient to methylene blue during breast surgery with sentinel node mapping , 2010, Acta oncologica.

[12]  R. Sadeghi,et al.  Factors affecting sentinel lymph node detection failure in breast cancer patients using intradermal injection of the tracer. , 2010, Revista espanola de medicina nuclear.

[13]  I. V. D. van der Ploeg,et al.  Visualization of Tumor Blockage and Rerouting of Lymphatic Drainage in Penile Cancer Patients by Use of SPECT/CT , 2009, Journal of Nuclear Medicine.

[14]  S. Swanson,et al.  Intraoperative Sentinel Node Mapping with Technitium-99 in Lung Cancer: Results of CALGB 140203 Multicenter Phase II Trial , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[15]  M. Liptay In Vivo Sentinel Lymph Node Mapping in Lung Cancer , 2005, Annals of Surgical Oncology.

[16]  S. Horenblas,et al.  Re: Gipponi M, Solari N, Di Somma FC, et al.: New fields of application of the sentinel lymph node biopsy in the pathologic staging of solid neoplasms: Review of literature and surgical perspectives. J Surg Oncol 2004: 85:171–179 , 2004, Journal of surgical oncology.

[17]  Franco C Di Somma,et al.  New fields of application of the sentinel lymph node biopsy in the pathologic staging of solid neoplasms: Review of literature and surgical perspectives , 2004, Journal of surgical oncology.

[18]  Qiu-li Li,et al.  [Review of relationship between vascular endothelial growth factor C & D and lymph node metastasis of malignant tumor]. , 2002, Ai zheng = Aizheng = Chinese journal of cancer.

[19]  M. Keshtgar,et al.  The efficacy of Tc-99m sestamibi for sentinel node mapping in breast carcinomas: comparison with Tc-99m antimony sulphide colloid. , 2010, Nuclear medicine review. Central & Eastern Europe.